To deobligate remaining fiscal year 2015 funding in preparation for the september 30, 2020 closing of the period of availability of these fiscal year funds. All other terms and conditions remain…
Ended Purchase Order Awarded Last action
- Contract number
- HHSN271201500489P
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,620
Award facts
- Contract value 100% obligated
- $23,619.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$100 | |
| Original award | $23,720 |
About this award
This federal contract award was issued by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services. The $23,619.60 firm fixed-price purchase order was awarded to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, a leading manufacturer of scientific instruments, reagents, and consumables. The contract supports the delivery of genetic analyzers, reagents, assays, instruments, and associated repair services to enable federal initiatives related to healthcare, medical readiness, and forensic analysis. This award was not set aside for any specific program. Life Technologies has established itself as a prime contractor across various federal agencies, including the National Institutes of Health, Department of Defense, and Department of Justice, providing specialized biotechnology products and services. The company has also participated as a subcontractor and subgrantee on research projects, contributing analytical instruments and expertise to support initiatives such as the National Institute of Justice's DNA Capacity Enhancement and Backlog Reduction Program.
Description
To deobligate remaining fiscal year 2015 funding in preparation for the september 30, 2020 closing of the period of availability of these fiscal year funds. All other terms and conditions remain unchanged
Quick answers
Who was awarded contract HHSN271201500489P?
HHSN271201500489P was awarded to Life Technologies Corporation by National Institute on Drug Abuse (National Institutes of Health) on July 1, 2015.
How much is contract HHSN271201500489P worth?
The government has obligated $23,620 on HHSN271201500489P.
Which agency awarded contract HHSN271201500489P?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201500489P, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract HHSN271201500489P competed?
The extent of competition for HHSN271201500489P was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award